Table 4 Significant P-values according to differential expression analysis of biological pathways
From: Multiple model species selection for transcriptomics analysis of non-model organisms
Pathway ID | Pathway name | crg | crg/lgi | crg/lgi/bfo | crg/lgi/hroa |
|---|---|---|---|---|---|
ko04514 | Cell adhesion molecules (CAMs) | Â | Â | Â | 8.03E-05 |
ko05020 | Prion diseases | Â | 8.12E-03 | 8.10E-03 | 5.95E-04 |
ko04610 | Complement and coagulation cascades | Â | 1.14E-03 | 1.14E-03 | 1.84E-03 |
ko04330 | Notch signaling pathway | Â | 2.51E-03 | 2.14E-03 | 4.98E-03 |
ko00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | Â | 2.80E-03 | 2.80E-03 | 6.23E-03 |
ko04974 | Protein digestion and absorption | Â | 2.31E-02 | 2.30E-02 | 5.74E-03 |
ko00740 | Riboflavin metabolism | 9.46E-03 | 4.17E-02 | Â | Â |
ko04977 | Vitamin digestion and absorption | Â | Â | Â | 1.04E-02 |
ko04540 | Gap junction | Â | 1.06E-02 | 1.05E-02 | 2.37E-02 |
ko04978 | Mineral absorption | Â | 1.58E-02 | 1.37E-02 | 2.49E-02 |
ko05150 | Staphylococcus aureus infection | Â | 1.41E-02 | 1.41E-02 | 1.79E-02 |
ko00350 | Tyrosine metabolism | 6.47E-02 | 1.58E-02 | Â | 2.49E-02 |
ko05130 | Pathogenic Escherichia coli infection | Â | 2.31E-02 | 2.05E-02 | 3.60E-02 |
ko04512 | ECM-receptor interaction | 4.66E-02 | 2.31E-02 | 2.30E-02 | Â |
ko04145 | Phagosome | Â | 2.74E-02 | 2.44E-02 | Â |
ko00965 | Betalain biosynthesis | Â | 2.80E-02 | Â | Â |
ko04391 | Hippo signaling pathway - fly | Â | Â | Â | 2.94E-02 |
ko04210 | Apoptosis | Â | 4.74E-02 | 3.74E-02 | Â |